Loading…
The role of miRNA-377 as a tumor suppressor in lung cancer by negative regulation of genes belonging to ErbB signaling pathway
Background The ErbB signaling pathway plays important role in the pathogenesis of lung cancer. We explored the role of miRNA-377 as a tumor suppressor in NSCLC through silencing of some genes in the ErbB pathway. Methods and Results The targeting effect of miRNA-377 on EGFR, MAPK1, ABL2, and PAK2 wa...
Saved in:
Published in: | Molecular biology reports 2022, Vol.49 (1), p.85-95 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c419t-fb720c2a00758a881af614a88fd3316f8e6659fe78926989c9daa83960f20f823 |
---|---|
cites | cdi_FETCH-LOGICAL-c419t-fb720c2a00758a881af614a88fd3316f8e6659fe78926989c9daa83960f20f823 |
container_end_page | 95 |
container_issue | 1 |
container_start_page | 85 |
container_title | Molecular biology reports |
container_volume | 49 |
creator | Hashemi, Saba Yari, Naghmeh Rahimi Jamnani, Fatemeh Mahdian, Reza Karimi, Morteza Zeinali, Sirous Rafiee, Mohammad Hesam Azizi, Masoumeh |
description | Background
The ErbB signaling pathway plays important role in the pathogenesis of lung cancer. We explored the role of miRNA-377 as a tumor suppressor in NSCLC through silencing of some genes in the ErbB pathway.
Methods and Results
The targeting effect of miRNA-377 on EGFR, MAPK1, ABL2, and PAK2 was evaluated. The expression levels of these genes and miRNA-377 were surveyed in NSCLC and normal human tissues, Calu-6, and A549 cells. Real-time PCR was used to figure out whether miRNA-377 could decrease the target genes mRNAs in transfected lung cancer cell lines. The effects of miRNA-377 on apoptosis cell and proliferation were analyzed. We showed that miRNA-377 targets EGFR, MAPK1, and PAK2 mRNAs in in-silico and luciferase reporter assay. The expression of miRNA-377 was significantly downregulated in human NSCLC tissues, Calu-6 and A549 cells compared to their controls. We observed a negative correlation between EGFR, MAPK1, PAK2, and miRNA-377 expression in human NSCLC tissues. A significant reduction in EGFR, MAPK1, and PAK2 mRNA levels was detected, following miRNA-377 transfection in Calu-6 and A549 cells. The higher levels of miRNA-377 in Calu-6, and A549 cells induced apoptosis and reduced proliferation, significantly.
Conclusions
All these data reveal that miRNA-377 functions as a tumor suppressor in NSCLC and may serve as a potential therapeutic target for the treatment of NSCLC. |
doi_str_mv | 10.1007/s11033-021-06844-6 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2584018141</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2618382186</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-fb720c2a00758a881af614a88fd3316f8e6659fe78926989c9daa83960f20f823</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhS1ERZfCH-CALHHhYvDYjuMcS9UWpIpKVTlbTnacpkrsYCdFe-G34-0WkDhw8pPne88ePULeAP8AnNcfMwCXknEBjGujFNPPyAaqWjLV1OY52XDJgSlTwTF5mfM951xBXb0gx1JpbYDDhvy8vUOa4og0ejoNN19Pmaxr6jJ1dFmnmGhe5zlhzkUOgY5r6GnnQoeJtjsasHfL8FAisF_HImPYB_UYMNMWxxj6oRiWSM9T-4nmoQ9u3N_Mbrn74XavyJF3Y8bXT-cJ-XZxfnv2mV1dX345O71inYJmYb6tBe-EK1tXxhkDzmtQRfitlKC9Qa2rxmNtGqEb03TN1jkjG8294N4IeULeH3LnFL-vmBc7DbnDcXQB45qtqIziYEBBQd_9g97HNZVvF0qDkUaA0YUSB6pLMeeE3s5pmFzaWeB23449tGNLO_axHbs3vX2KXtsJt38sv-sogDwAuYxCj-nv2_-J_QUI9Jkb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2618382186</pqid></control><display><type>article</type><title>The role of miRNA-377 as a tumor suppressor in lung cancer by negative regulation of genes belonging to ErbB signaling pathway</title><source>Springer Link</source><creator>Hashemi, Saba ; Yari, Naghmeh ; Rahimi Jamnani, Fatemeh ; Mahdian, Reza ; Karimi, Morteza ; Zeinali, Sirous ; Rafiee, Mohammad Hesam ; Azizi, Masoumeh</creator><creatorcontrib>Hashemi, Saba ; Yari, Naghmeh ; Rahimi Jamnani, Fatemeh ; Mahdian, Reza ; Karimi, Morteza ; Zeinali, Sirous ; Rafiee, Mohammad Hesam ; Azizi, Masoumeh</creatorcontrib><description>Background
The ErbB signaling pathway plays important role in the pathogenesis of lung cancer. We explored the role of miRNA-377 as a tumor suppressor in NSCLC through silencing of some genes in the ErbB pathway.
Methods and Results
The targeting effect of miRNA-377 on EGFR, MAPK1, ABL2, and PAK2 was evaluated. The expression levels of these genes and miRNA-377 were surveyed in NSCLC and normal human tissues, Calu-6, and A549 cells. Real-time PCR was used to figure out whether miRNA-377 could decrease the target genes mRNAs in transfected lung cancer cell lines. The effects of miRNA-377 on apoptosis cell and proliferation were analyzed. We showed that miRNA-377 targets EGFR, MAPK1, and PAK2 mRNAs in in-silico and luciferase reporter assay. The expression of miRNA-377 was significantly downregulated in human NSCLC tissues, Calu-6 and A549 cells compared to their controls. We observed a negative correlation between EGFR, MAPK1, PAK2, and miRNA-377 expression in human NSCLC tissues. A significant reduction in EGFR, MAPK1, and PAK2 mRNA levels was detected, following miRNA-377 transfection in Calu-6 and A549 cells. The higher levels of miRNA-377 in Calu-6, and A549 cells induced apoptosis and reduced proliferation, significantly.
Conclusions
All these data reveal that miRNA-377 functions as a tumor suppressor in NSCLC and may serve as a potential therapeutic target for the treatment of NSCLC.</description><identifier>ISSN: 0301-4851</identifier><identifier>EISSN: 1573-4978</identifier><identifier>DOI: 10.1007/s11033-021-06844-6</identifier><identifier>PMID: 34668101</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>3' Untranslated Regions ; A549 Cells ; Animal Anatomy ; Animal Biochemistry ; Apoptosis ; Biomedical and Life Sciences ; Carcinoma, Non-Small-Cell Lung - genetics ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Cell Survival ; Down-Regulation ; Epidermal growth factor receptors ; ErbB protein ; ErbB Receptors - genetics ; Gene Expression Regulation, Neoplastic ; Gene regulation ; Gene silencing ; Histology ; Humans ; Life Sciences ; Lung cancer ; Lung Neoplasms - genetics ; MicroRNAs - genetics ; miRNA ; Mitogen-Activated Protein Kinase 1 - genetics ; Morphology ; mRNA ; Non-small cell lung carcinoma ; Original Article ; p21-Activated Kinases - genetics ; Signal Transduction ; Therapeutic targets ; Transfection ; Tumor cell lines ; Tumor suppressor genes ; Tumors</subject><ispartof>Molecular biology reports, 2022, Vol.49 (1), p.85-95</ispartof><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer Nature B.V.</rights><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c419t-fb720c2a00758a881af614a88fd3316f8e6659fe78926989c9daa83960f20f823</citedby><cites>FETCH-LOGICAL-c419t-fb720c2a00758a881af614a88fd3316f8e6659fe78926989c9daa83960f20f823</cites><orcidid>0000-0003-4679-3248</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34668101$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hashemi, Saba</creatorcontrib><creatorcontrib>Yari, Naghmeh</creatorcontrib><creatorcontrib>Rahimi Jamnani, Fatemeh</creatorcontrib><creatorcontrib>Mahdian, Reza</creatorcontrib><creatorcontrib>Karimi, Morteza</creatorcontrib><creatorcontrib>Zeinali, Sirous</creatorcontrib><creatorcontrib>Rafiee, Mohammad Hesam</creatorcontrib><creatorcontrib>Azizi, Masoumeh</creatorcontrib><title>The role of miRNA-377 as a tumor suppressor in lung cancer by negative regulation of genes belonging to ErbB signaling pathway</title><title>Molecular biology reports</title><addtitle>Mol Biol Rep</addtitle><addtitle>Mol Biol Rep</addtitle><description>Background
The ErbB signaling pathway plays important role in the pathogenesis of lung cancer. We explored the role of miRNA-377 as a tumor suppressor in NSCLC through silencing of some genes in the ErbB pathway.
Methods and Results
The targeting effect of miRNA-377 on EGFR, MAPK1, ABL2, and PAK2 was evaluated. The expression levels of these genes and miRNA-377 were surveyed in NSCLC and normal human tissues, Calu-6, and A549 cells. Real-time PCR was used to figure out whether miRNA-377 could decrease the target genes mRNAs in transfected lung cancer cell lines. The effects of miRNA-377 on apoptosis cell and proliferation were analyzed. We showed that miRNA-377 targets EGFR, MAPK1, and PAK2 mRNAs in in-silico and luciferase reporter assay. The expression of miRNA-377 was significantly downregulated in human NSCLC tissues, Calu-6 and A549 cells compared to their controls. We observed a negative correlation between EGFR, MAPK1, PAK2, and miRNA-377 expression in human NSCLC tissues. A significant reduction in EGFR, MAPK1, and PAK2 mRNA levels was detected, following miRNA-377 transfection in Calu-6 and A549 cells. The higher levels of miRNA-377 in Calu-6, and A549 cells induced apoptosis and reduced proliferation, significantly.
Conclusions
All these data reveal that miRNA-377 functions as a tumor suppressor in NSCLC and may serve as a potential therapeutic target for the treatment of NSCLC.</description><subject>3' Untranslated Regions</subject><subject>A549 Cells</subject><subject>Animal Anatomy</subject><subject>Animal Biochemistry</subject><subject>Apoptosis</subject><subject>Biomedical and Life Sciences</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>Cell Line, Tumor</subject><subject>Cell Movement</subject><subject>Cell Proliferation</subject><subject>Cell Survival</subject><subject>Down-Regulation</subject><subject>Epidermal growth factor receptors</subject><subject>ErbB protein</subject><subject>ErbB Receptors - genetics</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Gene regulation</subject><subject>Gene silencing</subject><subject>Histology</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - genetics</subject><subject>MicroRNAs - genetics</subject><subject>miRNA</subject><subject>Mitogen-Activated Protein Kinase 1 - genetics</subject><subject>Morphology</subject><subject>mRNA</subject><subject>Non-small cell lung carcinoma</subject><subject>Original Article</subject><subject>p21-Activated Kinases - genetics</subject><subject>Signal Transduction</subject><subject>Therapeutic targets</subject><subject>Transfection</subject><subject>Tumor cell lines</subject><subject>Tumor suppressor genes</subject><subject>Tumors</subject><issn>0301-4851</issn><issn>1573-4978</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kUFv1DAQhS1ERZfCH-CALHHhYvDYjuMcS9UWpIpKVTlbTnacpkrsYCdFe-G34-0WkDhw8pPne88ePULeAP8AnNcfMwCXknEBjGujFNPPyAaqWjLV1OY52XDJgSlTwTF5mfM951xBXb0gx1JpbYDDhvy8vUOa4og0ejoNN19Pmaxr6jJ1dFmnmGhe5zlhzkUOgY5r6GnnQoeJtjsasHfL8FAisF_HImPYB_UYMNMWxxj6oRiWSM9T-4nmoQ9u3N_Mbrn74XavyJF3Y8bXT-cJ-XZxfnv2mV1dX345O71inYJmYb6tBe-EK1tXxhkDzmtQRfitlKC9Qa2rxmNtGqEb03TN1jkjG8294N4IeULeH3LnFL-vmBc7DbnDcXQB45qtqIziYEBBQd_9g97HNZVvF0qDkUaA0YUSB6pLMeeE3s5pmFzaWeB23449tGNLO_axHbs3vX2KXtsJt38sv-sogDwAuYxCj-nv2_-J_QUI9Jkb</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Hashemi, Saba</creator><creator>Yari, Naghmeh</creator><creator>Rahimi Jamnani, Fatemeh</creator><creator>Mahdian, Reza</creator><creator>Karimi, Morteza</creator><creator>Zeinali, Sirous</creator><creator>Rafiee, Mohammad Hesam</creator><creator>Azizi, Masoumeh</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4679-3248</orcidid></search><sort><creationdate>2022</creationdate><title>The role of miRNA-377 as a tumor suppressor in lung cancer by negative regulation of genes belonging to ErbB signaling pathway</title><author>Hashemi, Saba ; Yari, Naghmeh ; Rahimi Jamnani, Fatemeh ; Mahdian, Reza ; Karimi, Morteza ; Zeinali, Sirous ; Rafiee, Mohammad Hesam ; Azizi, Masoumeh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-fb720c2a00758a881af614a88fd3316f8e6659fe78926989c9daa83960f20f823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>3' Untranslated Regions</topic><topic>A549 Cells</topic><topic>Animal Anatomy</topic><topic>Animal Biochemistry</topic><topic>Apoptosis</topic><topic>Biomedical and Life Sciences</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>Cell Line, Tumor</topic><topic>Cell Movement</topic><topic>Cell Proliferation</topic><topic>Cell Survival</topic><topic>Down-Regulation</topic><topic>Epidermal growth factor receptors</topic><topic>ErbB protein</topic><topic>ErbB Receptors - genetics</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Gene regulation</topic><topic>Gene silencing</topic><topic>Histology</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - genetics</topic><topic>MicroRNAs - genetics</topic><topic>miRNA</topic><topic>Mitogen-Activated Protein Kinase 1 - genetics</topic><topic>Morphology</topic><topic>mRNA</topic><topic>Non-small cell lung carcinoma</topic><topic>Original Article</topic><topic>p21-Activated Kinases - genetics</topic><topic>Signal Transduction</topic><topic>Therapeutic targets</topic><topic>Transfection</topic><topic>Tumor cell lines</topic><topic>Tumor suppressor genes</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hashemi, Saba</creatorcontrib><creatorcontrib>Yari, Naghmeh</creatorcontrib><creatorcontrib>Rahimi Jamnani, Fatemeh</creatorcontrib><creatorcontrib>Mahdian, Reza</creatorcontrib><creatorcontrib>Karimi, Morteza</creatorcontrib><creatorcontrib>Zeinali, Sirous</creatorcontrib><creatorcontrib>Rafiee, Mohammad Hesam</creatorcontrib><creatorcontrib>Azizi, Masoumeh</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular biology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hashemi, Saba</au><au>Yari, Naghmeh</au><au>Rahimi Jamnani, Fatemeh</au><au>Mahdian, Reza</au><au>Karimi, Morteza</au><au>Zeinali, Sirous</au><au>Rafiee, Mohammad Hesam</au><au>Azizi, Masoumeh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of miRNA-377 as a tumor suppressor in lung cancer by negative regulation of genes belonging to ErbB signaling pathway</atitle><jtitle>Molecular biology reports</jtitle><stitle>Mol Biol Rep</stitle><addtitle>Mol Biol Rep</addtitle><date>2022</date><risdate>2022</risdate><volume>49</volume><issue>1</issue><spage>85</spage><epage>95</epage><pages>85-95</pages><issn>0301-4851</issn><eissn>1573-4978</eissn><abstract>Background
The ErbB signaling pathway plays important role in the pathogenesis of lung cancer. We explored the role of miRNA-377 as a tumor suppressor in NSCLC through silencing of some genes in the ErbB pathway.
Methods and Results
The targeting effect of miRNA-377 on EGFR, MAPK1, ABL2, and PAK2 was evaluated. The expression levels of these genes and miRNA-377 were surveyed in NSCLC and normal human tissues, Calu-6, and A549 cells. Real-time PCR was used to figure out whether miRNA-377 could decrease the target genes mRNAs in transfected lung cancer cell lines. The effects of miRNA-377 on apoptosis cell and proliferation were analyzed. We showed that miRNA-377 targets EGFR, MAPK1, and PAK2 mRNAs in in-silico and luciferase reporter assay. The expression of miRNA-377 was significantly downregulated in human NSCLC tissues, Calu-6 and A549 cells compared to their controls. We observed a negative correlation between EGFR, MAPK1, PAK2, and miRNA-377 expression in human NSCLC tissues. A significant reduction in EGFR, MAPK1, and PAK2 mRNA levels was detected, following miRNA-377 transfection in Calu-6 and A549 cells. The higher levels of miRNA-377 in Calu-6, and A549 cells induced apoptosis and reduced proliferation, significantly.
Conclusions
All these data reveal that miRNA-377 functions as a tumor suppressor in NSCLC and may serve as a potential therapeutic target for the treatment of NSCLC.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>34668101</pmid><doi>10.1007/s11033-021-06844-6</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-4679-3248</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0301-4851 |
ispartof | Molecular biology reports, 2022, Vol.49 (1), p.85-95 |
issn | 0301-4851 1573-4978 |
language | eng |
recordid | cdi_proquest_miscellaneous_2584018141 |
source | Springer Link |
subjects | 3' Untranslated Regions A549 Cells Animal Anatomy Animal Biochemistry Apoptosis Biomedical and Life Sciences Carcinoma, Non-Small-Cell Lung - genetics Cell Line, Tumor Cell Movement Cell Proliferation Cell Survival Down-Regulation Epidermal growth factor receptors ErbB protein ErbB Receptors - genetics Gene Expression Regulation, Neoplastic Gene regulation Gene silencing Histology Humans Life Sciences Lung cancer Lung Neoplasms - genetics MicroRNAs - genetics miRNA Mitogen-Activated Protein Kinase 1 - genetics Morphology mRNA Non-small cell lung carcinoma Original Article p21-Activated Kinases - genetics Signal Transduction Therapeutic targets Transfection Tumor cell lines Tumor suppressor genes Tumors |
title | The role of miRNA-377 as a tumor suppressor in lung cancer by negative regulation of genes belonging to ErbB signaling pathway |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T13%3A03%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20miRNA-377%20as%20a%20tumor%20suppressor%20in%20lung%20cancer%20by%20negative%20regulation%20of%20genes%20belonging%20to%20ErbB%20signaling%20pathway&rft.jtitle=Molecular%20biology%20reports&rft.au=Hashemi,%20Saba&rft.date=2022&rft.volume=49&rft.issue=1&rft.spage=85&rft.epage=95&rft.pages=85-95&rft.issn=0301-4851&rft.eissn=1573-4978&rft_id=info:doi/10.1007/s11033-021-06844-6&rft_dat=%3Cproquest_cross%3E2618382186%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c419t-fb720c2a00758a881af614a88fd3316f8e6659fe78926989c9daa83960f20f823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2618382186&rft_id=info:pmid/34668101&rfr_iscdi=true |